AI Article Synopsis
- Oily chemoembolization has been traditionally used for liver cancer, but this case explores its application for pancreatic cancer.
- A 48-year-old patient with inoperable pancreatic adenocarcinoma underwent 10 treatments using gemcitabine-in-lipiodol, resulting in significant tumor reduction and no viable tumor detected on imaging.
- The patient remains alive and symptom-free 22 months post-treatment, suggesting that oily chemoembolization could be a viable palliative option for pancreatic head carcinoma.
Article Abstract
Oily chemoembolization is a known method of treatment for hepatic malignancies but was never used for pancreatic cancer. We report the case of a 48-year-old patient with unresectable adenocarcinoma of the pancreatic head treated by repeated chemoembolizations of the feeding (gastroduodenal) artery with gemcitabine-in-lipiodol. After 10 procedures there was a marked decrease in tumor. Radiologic examinations showed no signs of viable tumor. The patient is alive and symptom-free 22 months after the start of treatment. Oily chemoembolization should be investigated as a technically simple, safe, and potentially effective palliative management of unresectable pancreatic head carcinoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00270-001-0040-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!